9/24/2021 8:35:47 AM
Onconova Therapeutics Prices Public Offering Of 5 Mln Shares At $4.20/Shr
6/28/2021 8:28:42 AM
Onconova Therapeutics Provides Update On Phase 1/2a Trial Of Rigosertib-Nivolumab Combination In KRAS+ NSCLC
1/7/2021 9:41:44 AM
Onconova Therapeutics Reports $8.7 Mln Public Offering